Share
News
-
31 August 2009 /Side effects and trials
Beware of mix-ups between products containing mirtazapine and mianserin
The Danish Medicines Agency has been informed through the Danish Patient Safety Database of six adverse incidents in the period from March 2007 to June 2009 involving the mix-up of medicines containing the active substances mirtazapine and mianserin.
-
27 August 2009 /Side effects and trials
Side effects from medicines used to prevent or treat influenza A (H1N1)
In here you will find the side effects from antiviral drugs such as Tamiflu® and Relenza® and the side effects from the vaccines for the prevention of influenza A (H1N1).
-
26 August 2009 /Side effects and trials
About prevention and treatment of influenza
In Denmark, an influenza virus typically occurs every autumn or winter. If you have had the disease - or if you have been vaccinated against it - you will not catch it again the same year/season.
-
26 August 2009 /Product information
Danish Medicines Agency hosts conference on biosimulation
Christiansborg Palace in Copenhagen sets the scene for a three-day conference where a group of leading scientists meet to take stock of recent years' progress of using computer modelling to develop medicines, an area also known as biosimulation.
-
17 August 2009 | Updated 24 August 2009 /Side effects and trials
Contraceptive pills and the risk of blood clots
A new Danish study confirms that women taking contraceptive pills have an increased risk of blood clots compared to women who do not take contraceptive pills.
-
04 August 2009 /Prices and reimbursement
Decision on the future reimbursement status of medicinal products in ATC group A08 (antiobesity preparations, excl. diet products)
On 3 July 2009, the Danish Medicines Agency made a decision on the future reimbursement status of medicinal products in ATC group A08 (antiobesity preparations excl. diet products).
